CLOV vs MRK · rev $1.37B vs P/E 33, rev $65.01B
Clover Health Investments Corp (CLOV) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
CLOV currently screens at market cap $1.55B. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the CLOV and MRK stock pages for the full models.
Not investment advice.